TME(TME)
TME
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $35.81B | $39.13B | $42.33B | $41.97B |
| Low | $34.65B | $37.67B | $38.77B | $39.69B |
| High | $37.31B | $42.97B | $47.41B | $45.64B |
| EBITDA Avg | $9.68B | $10.58B | $11.45B | $11.35B |
| Low | $9.37B | $10.19B | $10.48B | $10.73B |
| High | $10.09B | $11.62B | $12.82B | $12.34B |
| EBIT Avg | $8.43B | $9.21B | $9.97B | $9.88B |
| Low | $8.16B | $8.87B | $9.13B | $9.34B |
| High | $8.78B | $10.11B | $11.16B | $10.74B |
| Net Income Avg | $9.43B | $10.45B | $13.55B | $12.10B |
| Low | $9.08B | $10.20B | $9.95B | $11.25B |
| High | $9.77B | $10.70B | $17.14B | $13.48B |
| EPS Avg | $6.10 | $6.69 | $7.62 | $7.79 |
| Low | $5.84 | $6.56 | $6.40 | $7.24 |
| High | $6.29 | $6.89 | $11.03 | $8.67 |
| Analysts (Rev / EPS) | 19 / 12 | 19 / 13 | 21 / 12 | 10 / 9 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $9.23B | $9.41B | $8.62B | $9.89B | $9.81B | $9.93B | $9.31B | $10.70B |
| Low | $8.90B | $9.11B | $8.34B | $9.57B | $9.49B | $9.61B | $9.01B | $10.35B |
| High | $9.56B | $9.87B | $9.03B | $10.37B | $10.28B | $10.41B | $9.76B | $11.21B |
| EBITDA Avg | $2.50B | $2.55B | $2.33B | $2.68B | $2.65B | $2.69B | $2.52B | $2.89B |
| Low | $2.41B | $2.46B | $2.26B | $2.59B | $2.57B | $2.60B | $2.44B | $2.80B |
| High | $2.58B | $2.67B | $2.44B | $2.80B | $2.78B | $2.81B | $2.64B | $3.03B |
| EBIT Avg | $2.17B | $2.22B | $2.03B | $2.33B | $2.31B | $2.34B | $2.19B | $2.52B |
| Low | $2.10B | $2.14B | $1.96B | $2.25B | $2.23B | $2.26B | $2.12B | $2.44B |
| High | $2.25B | $2.32B | $2.13B | $2.44B | $2.42B | $2.45B | $2.30B | $2.64B |
| Net Income Avg | $2.40B | $2.52B | $2.37B | $2.65B | $2.69B | $2.84B | $2.56B | $2.70B |
| Low | $2.30B | $2.42B | $2.27B | $2.54B | $2.58B | $2.72B | $2.45B | $2.59B |
| High | $2.55B | $2.68B | $2.51B | $2.81B | $2.86B | $3.02B | $2.71B | $2.87B |
| EPS Avg | $1.54 | $1.62 | $1.52 | $1.70 | $1.73 | $1.83 | $1.64 | $1.74 |
| Low | $1.48 | $1.55 | $1.46 | $1.63 | $1.66 | $1.75 | $1.57 | $1.66 |
| High | $1.64 | $1.72 | $1.62 | $1.81 | $1.84 | $1.94 | $1.75 | $1.85 |
| Analysts (Rev / EPS) | 5 / 4 | 2 / 1 | 2 / 1 | 4 / 1 | 4 / 1 | 2 / 1 | 1 / 2 | 3 / 2 |